Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtaiBeckley (ATAI) Cash & Equivalents (2020 - 2026)

AtaiBeckley has reported Cash & Equivalents over the past 3 years, most recently at $43.1 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents changed N/A year-over-year to $43.1 million; the TTM value through Mar 2026 reached $43.1 million, changed N/A, while the annual FY2025 figure was $85.3 million, 387.29% up from the prior year.
  • Cash & Equivalents hit $30.4 million in Q3 2025 for AtaiBeckley, down from $61.9 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ATAI hit a ceiling of $453.6 million in Q2 2021 and a floor of $17.5 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $137.5 million across 5 years, with a median of $84.1 million in 2022.
  • On a YoY basis, Cash & Equivalents climbed as much as 387.29% in 2025 and fell as far as 387.29% in 2025.
  • Year by year, Cash & Equivalents stood at $17.5 million in 2024, then soared by 387.29% to $85.3 million in 2025, then plummeted by 49.47% to $43.1 million in 2026.
  • Business Quant data shows Cash & Equivalents for ATAI at $43.1 million in Q1 2026, $85.3 million in Q4 2025, and $17.5 million in Q4 2024.